MedTrace Logo

12 Steps of a Modified Handwashing Program on Health Outcomes and School Absenteeism

NCT07467902 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 802

Last updated 2026-03-12

No results posted yet for this study

Summary

The goal of this clinical trial is to assess whether providing hand and respiratory hygiene interventions in primary school children reduces the incidence rate of absence episodes due to illness in children during an academic year.

The main questions it aims to answer are:

This study aims to assess whether providing hand and respiratory hygiene interventions in primary school children reduces the incidence rate of absence episodes due to illness in children during an academic year.

1. Describe socio-demographic characteristics of participants (school children).
2. Assess the impact of hand and respiratory hygiene intervention on the incidence rate of respiratory illnesses.
3. Assess the impact of hand and respiratory hygiene intervention on the incidence rate of gastrointestinal illnesses.
4. Assess the impact of hand and respiratory hygiene intervention on the length of illness absence episodes.
5. Determine the factors associated with the increased or reduced impact of hand and respiratory hygiene intervention on school absenteeism.

Conditions

  • Respiratory Disease
  • Gastrointestinal Diseases and Symptom

Interventions

BEHAVIORAL

Hand Hygiene Education Program

Modified handwashing practice Children in intervention schools will receive an approximately 30 minutes of in-class hand hygiene education session at the beginning of the study. They will be instructed in the use of hand hygiene and asked to use it after coughing/sneezing and on the way out of the classroom for morning break and lunch. The in-class respiratory hygiene education sessions, Wearing masks and hand rub gel will be repeated every month. In addition, educational posters about hand hygiene, when and how to wash hands will be installed in each school (classrooms and/or corridors) as a reminder for schoolchildren.

Sponsors & Collaborators

  • Hawler Medical University

    lead OTHER

Principal Investigators

  • Nazar pols Shabila, Professor · Hawler Medical University/College of nursing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-05-15
Completion
2025-06-01

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07467902 on ClinicalTrials.gov